Introduction:
Following the decrease in immunization coverage and the recent measles outbreak, Italy has been the first EU country to increase up to 10 the number of compulsory vaccines (Law n.119/2017). Soon after, also France made mandatory 11 vaccines, however, the effectiveness of this approach is still matter of political debate and the scientific community is looking for evidence to identify the best strategy. This paper shows the actions performed by a Local Health Authority (LHA) and the main results after 8 months from the law implementation.
Methods:
By August 2017 the vaccination service of the area of Jesi (Marche Region) reviewed the immunization records of their 0-16y residents (total population:12.275 children). The parents of children who are not fully vaccinated have been invited to the LHA. The immunization records have been reviewed again by the 10th of March 2018 to calculate the catch-up rate. Furthermore the determinants which facilitate or hamper the immunization have been identified thought logistic regression models. Results: 2173 (17,7%) defaulting children has been invited to contact the LHA. 801 parents spontaneously decided to vaccinate their children or update their immunization record, while the remaining 1372 children (10.7%) received a letter with an appointment within one of the 51 dedicated sessions. 728 children (53.4%) received the mandatory vaccinations. This choice was significantly associated (p < 0.01) with the place of birth (OR = 0.73 for children born in the Marche Region), the year of birth (depending on the cohort), with sending letters based on standard format realized by antivaccination websites (OR = 0.24) and with the school requirements (OR = 2.22 for children attending nurseries).
Conclusions:
The law 119 required the LHA to deal with an increased amount of work related to inform and vaccinate defaulting children. Nevertheless, it allows an increase of vaccination coverage, as well as an improvement in the immunization registries.
Key messages:
Make more vaccines mandatory has been successful to speed up the catch-up of hesitant children, but a strong attention should be maintained to avoid a reduction in the uptake of recommended vaccines. Place and year of birth, using material from the antivaccination websites and school requirements are significantly associated with the acceptance of mandatory vaccines.
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Background:
Life expectancy has increased worldwide due to improved living conditions and health care. However, gains in total life expectancy (TLE) and disability-free life expectancy (DFLE) can vary considerably by sociodemographic factors and type of health condition. The present analysis investigated TLE and DFLE among persons with and without diabetes.
Methods:
The present study used data of three nationwide health telephone surveys conducted among adults in Germany 2009-2012 to assess the prevalence of physician-diagnosed diabetes and the prevalence of self-reported disability defined as being severely limited in daily activities due to diseases for at least six months. Data on all-cause mortality rates for the general population of Germany was drawn from the Federal Statistical Office of Germany. Mortality rate ratios for persons with diabetes compared to persons without diabetes were estimated based on 12-year mortality follow-up data of the nationwide GNHIES98 survey. Applying the Sullivan method, age-specific TLE and DFLE were estimated separately for men and women aged 65 years or older.
Results:
In both sexes and in all 5-year age-groups, TLE as well as DFLE were substantially lower for persons with than without diabetes. Among men aged 65-69 years, TLE and DFLE amounted to 14.3 and 10.2 years among those with diabetes as compared to 19.8 and 16.0 years among those without diabetes. Among women aged 65-69 years, TLE and DFLE estimates were 17.1 and 11.3 years for those with diabetes and 23.0 and 18.0 years for those without diabetes. Differences in TLE and DFLE between persons with and without diabetes attenuated with increasing age. The proportions of DFLE on TLE among people with and without diabetes were 71% and 81% in men and 66% and 78% in women.
Conclusions:
The present study revealed age-and sex-specific differences in TLE and DFLE related to diabetes and indicate that both, TLE and DFLE, should be integrated in a national diabetes surveillance.
Key messages:
The burden of diabetes with respect to mortality and disability was considerable in both sexes and the known female disadvantage in disability was accentuated in diabetes.
There is further need for efforts to reduce the burden of diabetes. In addition, specific intervention and prevention activities should be implemented to tackle disability in persons with diabetes.
A medical app to teenagers with type 1 diabetes: The development of a decision aid tool 
Background:
Mobile health (mHealth) technologies, such as apps, are increasingly promoted as a means of supporting users in health-related decision-making. These technologies influence the ways in which people engage in their health. The aim of this paper is to explore how a medical app 'Diapplo' affected teenagers' decision-making regarding diabetes management, with a specific focus on the processes involved in developing the app.
Methods:
A qualitative in-depth case study of the development and use of a medical app was conducted at two outpatient clinics in Denmark from October 2016 to December 2017. The app was developed using a participatory design approach, where users, health professionals and IT designers collaborated to develop an app to help teenagers with type 1 diabetes manage the disease in their daily lives and facilitate contact with health professionals. The app was tested by users and health professionals at two outpatient clinics. Data were generated during the developmental and test phases and comprise transcripts from meetings and workshops, interviews with the teenagers, observations, and material developed for inclusion in the app. The data were analysed using qualitative content analysis.
Results:
Analysis indicates that the teenagers' needs were not fully understood or met in the app. The teenagers rarely used the app to seek medical information to support decision-making; they would have preferred that there was a private space in the app to chat with other diabetics. Interacting with peers about everyday life situations without focusing on their disease was also considered a priority.
Conclusions:
Inspired by the theory of shared decision-making and patient engagement, we discuss the implications of our findings for developing a medical app to involve teenagers with a chronic disease in making health-related decisions.
Key messages:
Scoping of users' needs is required at initial stages and throughout the process of health app development.
Research is needed to understand how health apps can support teenagers with chronic diseases. 
Global impact of attaining the Sustainable Development Goal target for NCDs on longevity and economy

Background:
To curb the rising global burden of non-communicable diseases (NCDs), the United Nations (UN) Sustainable Development Goals (SDGs) include a target to reduce premature mortality from NCDs by one-third by 2030. A quantitative assessment of the long-term impact on longevity and economy by meeting this target is needed to advocate and inform national disease control policies.
Methods:
Applying cause-deleted life table methods to age-specific mortality rates in 183 countries in 2015 for the four major NCDs (cardiovascular diseases, cancers, chronic respiratory diseases and diabetes) from the World Health Organization Global Health Estimates, we estimated the potential gains in life expectancy (LE) in ages 30-70 years by eliminating onethird of the premature mortality from these diseases by country. We then quantified the corresponding total personyears expected to be gained in 2030-2070, and its impact on the economy by country, using population and GDP projections.
Results:
National life expectancy will rise if the target is met, corresponding to an average gain in LE in ages 30-70 years of 0.64 years worldwide for the four major NCDs. This would extend the number of person-years (PYs) to live in these age-groups by 1.4% (2.6 billion PYs) worldwide in 2030-2070. The economic benefit of the extended life expectancy would amount to $60.8 trillion (in 2005 USD) worldwide, with over half of which being generated in the 10 most populous countries globally.
Conclusions:
A one-third reduction in premature mortality from the major NCDs by 2030 would have significant long-term impact on longevity and economy worldwide. High-level political commitments to effective and equitable national surveillance and prioritized prevention, early detection and treatment programs, tailored to the major NCD types, are urgently needed if this SDG target is to be met by 2030.
Key messages:
Meeting the SDG target for NCDs would lead to significant longevity and economic gains. NCD prevention and control programs must be strengthened, to attain the SDG target for NCDs. 
Background:
In 2014 the United Nations (UN) committed to reducing premature mortality from non-communicable disease (NCD) via improving prevention and control. Evidence prior to 2014 showed that use of drugs for cardiovascular disease and hypertension was low globally, these drugs were inaccessible to many in lower-income countries, and NCD treatment costs imposed a significant economic burden on households. Using data since 2014, we examine the economic burden of treatment for NCD on households.
Methods:
Using data from 18 high-income (HIC), upper-middle-income (UMIC), lower-middle income (LMIC) and low-income (LIC) countries participating in the Prospective Urban and Rural Epidemiology Study, we estimate catastrophic spending and impoverishment among households containing at least one person with NCDs (N = 14,938), with hypertension only (N = 10,371) and with neither (N = 20,808). We estimate the odds of households containing someone with NCDs or hypertension experiencing catastrophic spending or impoverishment compared to those with neither. We also describe use of different financing sources and difficulties accessing care due to cost.
Results:
Catastrophic spending is highest among households with NCDs in LMIC, as is impoverishment. After adjustment, the odds of catastrophic spending in LMICs are higher in households with hypertension only and NCDs, with an increasing trend across groups (p < 0.001). A similar pattern is observed for impoverishment. The use of borrowing is most common in LICs; and many of those with NCDs in LIC reported not accessing care due to costs.
Conclusions:
The Third UN High Level Meeting on the Prevention and Control of NCDs will be held in 2018 to track progress made since 2014. Our findings show that we are far from achieving financial risk protection for people with NCDs, particularly in
